PCFA
By Dr Wendy Winnall - PCFA Research Team
Biopsy of the prostate remains the standard method for diagnosing prostate cancer. But biopsies are not perfect, they can be a bit "hit and miss". The way prostate biopsies are being done is changing. New types of biopsy and the results of the PROMIS trial are driving this change. There is debate amongst clinicians about how to perform prostate biopsies giving these new innovations. This week's blog examines what was said on this topic at the 2017 congress of the European Association of Urology.
/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.
